South Korea Biotechnology Reagents Market Insight
Published: 16 June 2026 | Report Format: Electronic (PDF)
The South Korea biotechnology reagents market is expected to grow at a CAGR of around 9.49% owing to increasing biopharmaceutical research activities, expanding genomics and proteomics applications, rising adoption of personalized medicine, growing biotechnology investments.
South Korea Biotechnology Reagents Market Insight Forecasts to 2035
- The South Korea Biotechnology Reagents Market Size was Estimated at USD 2.1 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 9.49% from 2025 to 2035
- The South Korea Biotechnology Reagents Market Size is Expected to Reach USD 5.2 Billion by 2035
Notable Insights for the South Korea Biotechnology Reagents Market
- Based on the Segmentation by Product Type, Molecular Biology segment is leading the South Korea Biotechnology Reagents Market in 2025, holding nearly 47% market share due to increasing demand for gene sequencing, cell-based research.
- Based on the Segmentation by Application, Biopharmaceutical Research segment accounted for approximately 59% market share in 2025, mainly driven by rising biologics development.
- The global revenue of Thermo Fisher Scientific Inc. in fiscal year 2025 stood at nearly USD 43 billion, supported by strong demand for life science reagents, laboratory consumables, analytical instrument.
- Increasing investments in genomics, precision medicine, AI-driven laboratory automation improve research productivity by nearly 38% while reducing experimental processing time by approximately 30%.
Download the eBook (ToC)
What Makes Decisions Advisors Research Unique?
• Intelligent Market Research Based on AI for Biotechnology & Life Sciences
Decisions Advisors provides intelligent market research covering biotechnology reagents, genomics technologies, molecular diagnostics, cell culture solutions, and biopharmaceutical research applications. The research identifies emerging opportunities, technology adoption trends, competitive positioning, and strategic developments shaping the South Korea Biotechnology Reagents Market.
• Highly Effective Research Approaches with Accurate Forecast Analysis
The research methodology incorporates primary interviews, biotechnology industry analysis, life sciences value-chain assessment, and data triangulation techniques to deliver accurate market sizing, growth forecasting, investment evaluation, and technology trend analysis. The study examines demand across pharmaceutical companies, biotechnology firms, academic institutions, and research laboratories.
• Highly Competitive Environment Analysis
The report provides comprehensive analysis of leading biotechnology reagent manufacturers, product innovations, strategic collaborations, research partnerships, regulatory developments, and expansion strategies. It also evaluates biotechnology infrastructure investments, R&D activities, and emerging opportunities within the South Korea Biotechnology Reagents Market.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Biotechnology Reagents Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea South Korea Biotechnology Reagents Market
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Merck KGaA
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- Takara Bio Inc.
- Promega Corporation
- Samsung Biologics Co., Ltd.
Recent Developments:
- In August 2025, Thermo Fisher Scientific Inc. expanded its biotechnology reagent portfolio with advanced genomic research solutions designed to improve sequencing efficiency and precision medicine applications.
- In May 2025, Takara Bio Inc. introduced next-generation cell culture and molecular biology reagents aimed at supporting biologics development and regenerative medicine research across Asia-Pacific markets.
Market Segmentation:
South Korea Biotechnology Reagents Market, By Product Type
- Molecular Biology Reagents
- Cell Culture Reagents
- Immunoassay Reagents
- Protein Analysis Reagents
- Chromatography & Purification Reagents
South Korea Biotechnology Reagents Market, By Technology
- Genomics
- Proteomics
- Cell Biology
- Bioinformatics & AI-Driven Research
- Molecular Diagnostics
South Korea Biotechnology Reagents Market, By Application
- Biopharmaceutical Research & Drug Development
- Clinical Diagnostics
- Academic & Research Institutes
- Agricultural Biotechnology
- Industrial Biotechnology
Expert Views:
The South Korea Biotechnology Reagents Market is poised for strong growth due to increasing investments in biotechnology research, expanding biologics manufacturing, and growing adoption of precision medicine. Advances in genomics, proteomics, molecular diagnostics, and AI-enabled laboratory automation are expected to enhance research efficiency and accelerate drug discovery. Furthermore, government support for biotechnology innovation, rising collaboration between academia and industry, and increasing demand for advanced life science tools will continue to strengthen market expansion through 2035.
Author: Sanket and Pranali By Decisions Advisors and Consulting